Latest News

Smaller voxel size may offer insights into biology we could never access with conventional resolution.

Catch up on the latest episodes of our Breast Imaging in Focus series with Manisha Bahl, MD, MPH, FSBI, discussing research on a variety of topics including breast arterial calcification on mammograms, automated breast ultrasound, AI and GLP-1 receptor agonists.

In a recently published review of the BI-RADS v2025 manual, leading breast radiologists offered pertinent insights on key changes for reporting of mammogram, breast ultrasound and breast MRI interpretation and assessment.

In a recent interview, Kay Jann, PhD, discussed challenges with urinary continence in stroke survivors and a forthcoming NIH-funded study examining the use of brain MRI to help identify those who may benefit from transcutaneous spinal cord stimulation (TSCS).

In comparison to 2023 statistics, the authors of a new study noted an approximately 49 percent increase in radiology turnaround time for ultrasound interpretation and over a 35 percent increase in turnaround time for X-ray assessments.

Extracellular volume fraction (ECV) assessment with photon-counting CT offered higher sensitivity and comparable specificity and AUC to magnetic resonance elastography (MRE)-derived liver stiffness measurement (LSM) for evaluating patients with stage 2 or higher fibrosis, according to a recent study.

New computed tomography (CT) research in July 2026 ranged from the ongoing impact of AI to significant declines in CT radiation dosing over the past decade to a growing recognition that coronary artery calcium (CAC) scoring alone may not be sufficient to convey a true picture of cardiovascular risk stratification.

The AI tools for the newly launched Invenia ABUS Prime ultrasound platform reportedly facilitate a 40 percent increase in scan speed and up to a 93 percent sensitivity rate for lesion detection in women with dense breasts.

While the vague “R/O pathology” has become pervasive filler for clinical history on requests for imaging, a new wave of clinical histories offer a word salad approach that offers equally little insight into the possible ailment of the patient.

Based on results from the phase III PSMAddition trial, the expanded approval may nearly double the number of patients with prostate cancer who can be treated with Pluvicto.

Combining automated lesion detection and characterization, the DeepHealth Breast Ultrasound software reportedly offers greater than 98 percent sensitivity for localizing breast lesions and reduces interpretation time for radiologists by 37 percent.

Offering rapid loading and viewing access for CT, MRI, ultrasound, PET imaging and mammograms, the ImageGrid® StreamVue platform can be integrated into existing PACS environments at hospitals and imaging centers.

Catch up on the most-well viewed radiology content in July 2026.